The microcentrifuge tube cell block method improves the cellularity yield for endobronchial ultrasound transbronchial needle aspiration specimens

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230713007

Enrollment

Registered

2023-07-13

Start date

2023-05-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mediastinal lymphadenopathy need tissue from EBUS-TBNA for lung cancer staging EBUS-TBNA, cell block, mediastinal lymphadenopathy

Interventions

Tissue sample aspirate from EBUS TBNA was prepared using micro centrifuge tube ,Tissue sample aspirate from EBUS TBNA was prepared using tissue coagulum method

Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

Microtubule ,Tissue coagulum method

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Mediastinal lymphadenopathy in CT chest size more than 1 cm PET CT show mediastinal LN larger than 1 cm or SUV uptake more than 2.5

Exclusion criteria

Exclusion criteria: Coagulopathy Deny participate in the study

Design outcomes

Primary

Measure	Time frame
Diagnostic yield Duration of pathologist report Pathologist report cell block	—

Secondary

Measure	Time frame
Cellular adequacy Duration of pathogist report Cytopathology report adequacy	—

Countries

Thailand

Contacts

Public ContactDuangrat Pruettivorawongse

Faculty of Medicine Ramathibodi Hospital, Mahidol University

bepruet@gmail.com66914156924

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026